Ocugen (OCGN)
(Delayed Data from NSDQ)
$1.28 USD
+0.10 (8.47%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.27 -0.01 (-0.78%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Income Statements
Fiscal Year end for Ocugen, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 6 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 6 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 72 | 85 | 58 | 21 | 14 |
Income After Depreciation & Amortization | -66 | -85 | -58 | -21 | -14 |
Non-Operating Income | 2 | 4 | 0 | 0 | -4 |
Interest Expense | 0 | 0 | 0 | 1 | 2 |
Pretax Income | -63 | -81 | -58 | -22 | -20 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -63 | -81 | -58 | -22 | -20 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -63 | -81 | -58 | -22 | -20 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -65 | -84 | -58 | -21 | -14 |
Depreciation & Amortization (Cash Flow) | 1 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -66 | -85 | -58 | -21 | -14 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 244.33 | 214.60 | 195.01 | 112.24 | 13.89 |
Diluted EPS Before Non-Recurring Items | -0.26 | -0.38 | -0.30 | -0.31 | -1.48 |
Diluted Net EPS (GAAP) | -0.26 | -0.38 | -0.30 | -0.31 | -1.46 |
Fiscal Year end for Ocugen, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 6.04 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 6.04 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 14.65 | 15.42 | 23.73 | 17.75 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -8.61 | -15.42 | -23.73 | -17.75 |
Non-Operating Income | NA | -0.87 | 1.26 | 0.81 | 1.25 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -9.49 | -14.16 | -22.93 | -16.50 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -9.49 | -14.16 | -22.93 | -16.50 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -9.49 | -14.16 | -22.93 | -16.50 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 270.41 | 256.49 | 238.31 | 225.52 |
Diluted EPS Before Non-Recurring Items | NA | -0.04 | -0.06 | -0.10 | -0.07 |
Diluted Net EPS (GAAP) | NA | -0.03 | -0.06 | -0.10 | -0.07 |